These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 32146004)
21. Prognostic significance of LncRNA GHET1 expression in various cancers: a systematic review and meta-analysis. Ye J; Sun H; Feng Z; Zhang Q; Xia Y; Ji Y; Zhang Q Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31227613 [TBL] [Abstract][Full Text] [Related]
22. LncRNA-ATB in cancers: what do we know so far? Tang F; Xu Y; Wang H; Bian E; Zhao B Mol Biol Rep; 2020 May; 47(5):4077-4086. PubMed ID: 32248383 [TBL] [Abstract][Full Text] [Related]
23. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis. Liu X; Huang G; Zhang J; Zhang L; Liang Z PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949 [TBL] [Abstract][Full Text] [Related]
24. The prognostic value of long noncoding RNA Sox2ot expression in various cancers: A systematic review and meta-analysis. Song X; Yao H; Liu J; Wang Q Clin Chim Acta; 2018 Sep; 484():52-59. PubMed ID: 29787741 [TBL] [Abstract][Full Text] [Related]
25. The prognostic value of high LncRNA AFAP1-AS1 expression in various cancers: A systematic review and meta-analysis containing 21 studies. Zhou Y; Chen S; Cheng S; Wei Q; Fathy AH; Shan T Clin Chim Acta; 2018 Jun; 481():147-153. PubMed ID: 29544748 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors. Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939 [TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and prognostic value of lncRNA PANDAR expression in solid tumors: Evidence from a systematic review and meta-analysis. Mehrad-Majd H; Akhtari J; Haerian MS; Ravanshad Y J Cell Physiol; 2019 Apr; 234(4):4206-4216. PubMed ID: 30191982 [TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA X-inactive specific transcript as a prognostic factor in cancer patients: A meta-analysis based on retrospective studies. Chen J; Yang X; Gong D; Cui Y; Hu J; Li H; Liu P; Li C; Cheng X; Liu L; Chen H; Zu X Medicine (Baltimore); 2019 Jan; 98(3):e14095. PubMed ID: 30653128 [TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA ATB promotes human non-small cell lung cancer proliferation and metastasis by suppressing miR-141-3p. Lu G; Zhang Y PLoS One; 2020; 15(2):e0229118. PubMed ID: 32092085 [TBL] [Abstract][Full Text] [Related]
30. Clinicopathological Significance of Long Non-Coding RNA GHET1 in Human Cancers: A Meta-Analysis. Poursheikhani A; Nokhandani N; Yousefi H; Rad DM; Sahebkar A Curr Pharm Biotechnol; 2020; 21(14):1422-1432. PubMed ID: 32720600 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of lncRNA ROR expression in various cancers: a meta-analysis. Lu R; Chen J; Kong L; Zhu H Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30076198 [No Abstract] [Full Text] [Related]
32. Study on the Expression of lncRNA ATB and Nek9 in Breast Cancer Patients Based on Q-PCR Technology and Its Relationship with the Disease. Zhaoyu Z; Huanyu X; Yajie Z; Ziyu D; Hui L; Feng S Contrast Media Mol Imaging; 2022; 2022():2634080. PubMed ID: 35935324 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma. Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634 [TBL] [Abstract][Full Text] [Related]
34. The expression and function of long noncoding RNA lncRNA-ATB in papillary thyroid cancer. Fu XM; Guo W; Li N; Liu HZ; Liu J; Qiu SQ; Zhang Q; Wang LC; Li F; Li CL Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3239-3246. PubMed ID: 28770959 [TBL] [Abstract][Full Text] [Related]
35. LncRNA Taurine Upregulated Gene 1 as a Potential Biomarker in the Clinicopathology and Prognosis of Multiple Malignant Tumors: A Meta-Analysis. Huang Q; Wu J; Wang H; Li N; Yang Z; Zhang M Dis Markers; 2021; 2021():8818363. PubMed ID: 33747256 [TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA-LET can indicate metastasis and a poor prognosis: a meta-analysis. Liu FT; Zhu PQ; Ou YX; Lin QS; Qiu C; Luo HL Minerva Med; 2016 Apr; 107(2):101-7. PubMed ID: 26963750 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers. Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476 [TBL] [Abstract][Full Text] [Related]
38. Upregulation of lncRNA SNHG1 is associated with metastasis and poor prognosis in cancers: A meta-analysis. Yu J; Yan Y; Hua C; Ming L Medicine (Baltimore); 2019 Apr; 98(16):e15196. PubMed ID: 31008944 [TBL] [Abstract][Full Text] [Related]
39. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma. Lee YR; Kim G; Tak WY; Jang SY; Kweon YO; Park JG; Lee HW; Han YS; Chun JM; Park SY; Hur K Int J Cancer; 2019 Mar; 144(6):1444-1452. PubMed ID: 30338850 [TBL] [Abstract][Full Text] [Related]
40. Prognostic and Clinicopathological Significance of lncRNA MVIH in Cancer Patients. Zhang Y; Lin S; Yang X; Zhang X J Cancer; 2019; 10(6):1503-1510. PubMed ID: 31031860 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]